Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Roche's six-hour sepsis test:

This article was originally published in Clinica

Executive Summary

Roche has CE-marked for sale in Europe a PCR-based test for sepsis that can identify the infection in less than six hours. The LightCycler SeptiFast test can detect several sepsis-causing pathogens simultaneously from just a three-millilitre sample of blood. It can detect and identify 25 different pathogens - including bacteria and fungi - which cause around 90% of all sepsis cases, said the Basel, Switzerland-based firm. Traditional tests for sepsis pathogens generally take from two to five days to complete, and up to eight days for the diagnosis of fungal infections, said the company. Roche noted that severe sepsis accounts for up to 135,000 European and 215,000 American deaths each year.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT050644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel